The contribution of BOP1 to colorectal tumorigenesis could be further explored in CRC cells that have lost p53 activity, since the inactivation of BOP1 in mouse TP53-KO 3T3 fibroblasts is associated with increased sensitivity to camptothecin cytotoxic treatment [128]. Here, TP53 is linked to colorectal carcinoma.